SAHEBJAM, Solmaz
$55,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
Evaluating the anti-tumor activity of a dual IGF-1R and IR inhibitor (OSI-906) in genomically characterized human breast cancer (BC) xenograft models.